Welcome and Introduction to Topics and Speakers (ID 4776)
Controlling cancer cell hallmarks to deliver breakthrough therapies (ID 4777)
Altering outcomes for rare tumors with new treatment options (ID 4778)
Rebooting checkpoint inhibition with smart combinations (ID 4779)
Deleting tumors through novel approaches to ramp up the immune system (ID 4780)
Closing and Key Takeaways (ID 4781)
